Skip to content

Laurel A. Habel , PhD

laurel.habel@kp.org

Kaiser Permanente Researcher Profiles

Habel, Laurel A.

Laurel Habel, PhD, has been a research scientist at the Kaiser Permanente Northern California Division of Research since 1996. Dr. Habel obtained her master’s in public health in epidemiology from the University of California, Los Angeles in 1980 and her doctorate in epidemiology from the University of Washington, Seattle in 1996. Dr. Habel’s research interests include the etiology and progression of cancer and precursor lesions for cancer; mammographic density and other biomarkers of disease risk or progression; and the association between use of medications and cancer risk. She is the principal investigator or site principal investigator on several federally-funded research projects.

Current Positions

  • Research Scientist III, Division of Research, Kaiser Permanente Northern California

Section Affiliations

Primary Research Interests

  • Breast cancer etiology and progression
  • Etiology and progression of precursor lesions for cancer
  • Mammographic density and other biomarkers of disease risk or progression
  • Use of medication and cancer risk

Studies

Multi-panel Gene Mutation Testing and Targeted Therapy -STRATA Program

Identify KPNC patients with metastatic/incurable cancer for testing of tumors by next generation sequencing (NGS). NGS screening protocol is aligned to a portfolio of pharma-sponsored therapeutic protocols open now or theoretically open in the future, in addition to treatment off study or on NCI or non-STRATA trials.

Investigator: Habel, Laurel

Funder: The Permanente Medical Group

NCI Community Oncology Research Program (NCORP) – KP Community Site

The overarching goal of the KP NCORP Community Site is to bring the benefits of medical advances to our racially and ethnically diverse membership and to the community at large by increasing clinical trial access/accrual and by conducting cancer care delivery research (CCDR).

Investigator: Habel, Laurel

Funder: National Cancer Institute

Genomic and Transcriptomic Analysis of Mammographic Density

This study will combine functional data from gene expression and co-expression networks with GWAS data to elucidate the genetic determinants of mammographic density, an important risk factor for breast cancer.

Investigator: Habel, Laurel

Funder: National Cancer Institute

Improved Selection of BRCA-negative High-Risk Women for Breast MRI Screening through Validation of IBIS Risk Model Variants

The goal of this project is to identify the optimal IBIS model that maximizes screening benefits and minimizes harms. We hypothesize that the “full” model (with all breast cancer risk factors) has better calibration/discrimination compared to a reduced model that includes age and family history only. We also hypothesize that that “full” model will improve cancer yield without affecting MRI referrals.

Investigator: Habel, Laurel

Funder: TPMG Delivery Science Projects Program

Developing a TPMG Pathway for Selective Oncotype DX Testing in Early Breast Cancer

The goal of this project is to determine whether Ki-67 testing, using newer methods, could be used as a replacement for Oncotype DX testing in selected patients with HR+/HER2- breast cancer.

Investigator: Habel, Laurel

Funder: TPMG Delivery Science Projects Program

Radiomic and genomic predictors of breast cancer risk

Improving breast cancer risk prediction models could enable more personalized screening. This would enhance the benefits of screening while limiting the harms. This study will evaluate the performance of multi-feature image risk score models in a large population-based cohort; determine whether image-based scores predict breast cancer risk independently of clinical and genetic predictors; and ransfer the best image-based algorithm from 2D to 3D images.

Investigator: Habel, Laurel

Funder: National Cancer Institute

Publications

Germline Genetic Testing Among Women ≤ 45 Years of Age with Ductal Carcinoma In Situ Versus Invasive Breast Cancer in a Large Integrated Health Care System

Authors: Hsu, Diana S;Jiang, Sheng-Fang;Habel, Laurel A;Hoodfar, Elizabeth;Karlea, Audrey;Manace-Brenman, Leslie;Dzubnar, Jessica M;Shim, Veronica C

Ann Surg Oncol. 2023 Oct;30(11):6454-6461. Epub 2023-06-29.

PubMed abstract

Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white women

Authors: Habel, Laurel A;Achacoso, Ninah;Sieh, Weiva;et al.

Breast Cancer Res. 2023 Aug 06;25(1):92. Epub 2023-08-06.

PubMed abstract

The Application of Lag Times in Cancer Pharmacoepidemiology: A Narrative Review

Authors: Hicks, Blánaid;Kaye, James A;Azoulay, Laurent;Kristensen, Kasper Bruun;Habel, Laurel A;Pottegård, Anton

Ann Epidemiol. 2023 Aug;84:25-32. Epub 2023-05-09.

PubMed abstract

Breast Cancer Recurrence by Subtype in a Diverse, Contemporary Cohort of Young Women

Authors: Vuong, Brooke;Darbinian, Jeanne;Savitz, Alison;Odele, Patience;Perry, Lauren M;Sandhu, Lakhbir;Habel, Laurel;Kuehner, Gillian

J Am Coll Surg. 2023 Jul 01;237(1):13-23. Epub 2023-04-13.

PubMed abstract

Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study

Authors: Arasu, Vignesh A;Kornak, John;Lewis, Donald A;Yoon, Hyo-Chun;Lee, Catherine;et al.

Radiology. 2023 Jun;307(5):e222733.

PubMed abstract

Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies

Authors: Pan, Minggui;Jiang, Chen;Zhang, Zheyang;Achacoso, Ninah;Solorzano-Pinto, Aleyda V;Tse, Pam;Chung, Elaine;Suga, Jennifer Marie;Thomas, Sachdev;Habel, Laurel A

Cancers (Basel). 2023 May 09;15(10). Epub 2023-05-09.

PubMed abstract

TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma

Authors: Pan, Minggui;Achacoso, Ninah;Thomas, Sachdev;Habel, Laurel A;et al.

JCO Precis Oncol. 2023 May;7:e2200570.

PubMed abstract

MiXcan: a framework for cell-type-aware transcriptome-wide association studies with an application to breast cancer

Authors: Song, Xiaoyu; Alexeeff, Stacey E; Sakoda, Lori C; Habel, Laurel A; Sieh, Weiva; et al.

Nat Commun. 2023 Jan 23;14(1):377. Epub 2023-01-23.

PubMed abstract

Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies

Authors: Cavazos, Taylor B; Alexeeff, Stacey; Van Den Eeden, Stephen; Corley, Douglas A; Kushi, Lawrence H; Habel, Laurel A; Sakoda, Lori C; Witte, John S; et al.

BMC Med. 2022 10 06;20(1):332. Epub 2022-10-06.

PubMed abstract

Anti-Müllerian hormone levels and breast cancer risk in the study of women’s health across the nation

Authors: Grimes, Nydjie P; Bertone-Johnson, Elizabeth R; Whitcomb, Brian W; Sievert, Lynnette L; Crawford, Sybil L; Gold, Ellen B; Avis, Nancy E; Greendale, Gail A; Santoro, Nanette; Habel, Laurel A; Reeves, Katherine W

Cancer Causes Control. 2022 Aug;33(8):1039-1046. Epub 2022-06-29.

PubMed abstract

Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic

Authors: Tang, Annie; Arasu, Vignesh A; Liu, Raymond; Habel, Laurel A; Kushi, Lawrence H; Chang, Sharon B; et al.

Perm J. 2022 06 29;26(2):54-63. Epub 2022-06-15.

PubMed abstract

Identification of Drug-Cancer Associations: A Nationwide Screening Study

Authors: Kristensen, Kasper Bruun; Friis, Søren; Lund, Lars Christian; Hallas, Jesper; Cardwell, Chris R; Andreassen, Bettina K; Habel, Laurel A; Pottegård, Anton

Cancer Res Commun. 2022 Jun;2(6):552-560. Epub 2022-06-29.

PubMed abstract

Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study

Authors: Scott, Oliver William; Tin Tin, Sandar; Elwood, J Mark; Cavadino, Alana; Habel, Laurel A; Kuper-Hommel, Marion; Campbell, Ian; Lawrenson, Ross

Breast Cancer Res Treat. 2022 May;193(1):225-235. Epub 2022-03-14.

PubMed abstract

Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci

Authors: Chen, Hongjie; Habel, Laurel A; Lindström, Sara; et al.

Breast Cancer Res. 2022 Apr 12;24(1):27. Epub 2022-04-12.

PubMed abstract

Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system

Authors: Tang, Annie; Arasu, Vignesh A; Liu, Raymond; Habel, Laurel A; Kushi, Lawrence H; Permanente Medical Group Breast Research Collaborative,; et al.

Breast Cancer Res Treat. 2022 Feb;191(3):665-675. Epub 2022-01-06.

PubMed abstract

TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer

Authors: Pan, Minggui; Solorzano, Aleyda V; Habel, Laurel A; et al.

J Clin Oncol. 2022 01 10;40(2):171-179. Epub 2021-11-29.

PubMed abstract

Hydrochlorothiazide and risk of melanoma subtypes

Authors: Habel, Laurel A; Achacoso, Ninah; Fireman, Bruce; Pedersen, Sidsel Arnspang; Pottegård, Anton

Pharmacoepidemiol Drug Saf. 2021 10;30(10):1396-1401. Epub 2021-05-26.

PubMed abstract

Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaska Native breast cancer survivors

Authors: Emerson, Marc A; Achacoso, Ninah S; Benefield, Halei C; Troester, Melissa A; Habel, Laurel A

Cancer. 2021 06 01;127(11):1847-1856. Epub 2021-02-23.

PubMed abstract

Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study

Authors: Solomon, Daniel H; Ruppert, Kristine; Habel, Laurel A; Finkelstein, Joel S; Lian, Pam; Joffe, Hadine; Kravitz, Howard M

BMJ Open. 2021 05 11;11(5):e045074. Epub 2021-05-11.

PubMed abstract

A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility

Authors: Emami, Nima C; Presti, Joseph; Habel, Laurel A; Sakoda, Lori C; Schaefer, Catherine; Van Den Eeden, Stephen K; Witte, John S; et al.

Cancer Res. 2021 04 01;81(7):1695-1703. Epub 2020-12-08.

PubMed abstract

Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts

Authors: Graff, Rebecca E; Alexeeff, Stacey E; Corley, Douglas A; Kushi, Lawrence H; Van Den Eeden, Stephen K; Habel, Laurel A; Sakoda, Lori C; et al.

Nat Commun. 2021 02 12;12(1):970. Epub 2021-02-12.

PubMed abstract

Risk of Renal Cell Carcinoma Associated with Calcium Channel Blockers: A Nationwide Observational Study Focusing on Confounding by Indication

Authors: Kristensen, Kasper Bruun; Habel, Laurel A; Gagne, Joshua J; Friis, Søren; Andersen, Klaus Kaae; Hallas, Jesper; Pottegård, Anton

Epidemiology. 2020 11;31(6):860-871.

PubMed abstract

Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk

Authors: Sieh, Weiva; Alexeeff, Stacey E; Sakoda, Lori C; Risch, Neil; Habel, Laurel A; et al.

Nat Commun. 2020 10 09;11(1):5116. Epub 2020-10-09.

PubMed abstract

Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts

Authors: Rashkin, Sara R; Alexeeff, Stacey E; Corley, Douglas A; Kushi, Lawrence H; Van Den Eeden, Stephen K; Habel, Laurel A; Sakoda, Lori C; Witte, John S; et al.

Nat Commun. 2020 09 04;11(1):4423. Epub 2020-09-04.

PubMed abstract

Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women’s Health Initiative

Authors: Reding KW; Habel LA; Chlebowski RT; et al.

Oncologist. 2020 08;25(8):712-721. Epub 2020-04-06.

PubMed abstract

Alcohol and tobacco use in relation to mammographic density in 23,456 women

Authors: McBride RB; Alexeeff SE; Sakoda LC; Habel LA; Sieh W; et al.

Cancer Epidemiol Biomarkers Prev. 2020 05;29(5):1039-1048. Epub 2020-02-17.

PubMed abstract

Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence

Authors: Lee C; Check DK; Manace Brenman L; Kushi LH; Epstein MM; Neslund-Dudas C; Pawloski PA; Achacoso N; Laurent C; Fehrenbacher L; Habel LA

Breast Cancer Res Treat. 2020 Feb;180(1):219-226. Epub 2020-01-23.

PubMed abstract

Re: Cancer outcomes in DCIS patients without locoregional treatment

Authors: Habel LA; Buist DSM

J Natl Cancer Inst. 2020 02 01;112(2):214-215.

PubMed abstract

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies

Authors: Watts EL; Habel LA; Schaefer CA; Van Den Eeden SK; Travis RC; et al.

Int J Cancer. 2019 12 15;145(12):3244-3256. Epub 2019-04-04.

PubMed abstract

Haloperidol and Prostate Cancer Prevention: More Epidemiologic Research Needed

Authors: Friedman GD; Habel LA; Achacoso N; Sanders CM; Oyer HM; Fireman B; Van Den Eeden SK; Kim FJ

Perm J. 2018;24. Epub 2019-11-22.

PubMed abstract

Blood pressure lowering medication initiation and fracture risk: a SWAN pharmacoepidemiology study

Authors: Solomon DH; Ruppert K; Kazlauskaite R; Finkelstein JS; Habel LA

Arch Osteoporos. 2019 06 28;14(1):73. Epub 2019-06-28.

PubMed abstract

Reproductive Factors and Mammographic Density: Associations Among 24,840 Women and Comparison of Studies Using Digitized Film-Screen Mammography and Full-Field Digital Mammography

Authors: Alexeeff SE; Habel LA; et al.

Am J Epidemiol. 2019 06 01;188(6):1144-1154.

PubMed abstract

Benign Papillary Breast Mass Lesions: Favorable Outcomes with Surgical Excision or Imaging Surveillance

Authors: Kuehner G; Darbinian J; Habel L; Axelsson K; Butler S; Chang S; Chen R; Fehrenbacher L

Ann Surg Oncol. 2019 Jun;26(6):1695-1703. Epub 2019-02-08.

PubMed abstract

Gabapentin and Cancer Risk: Updated Findings from Kaiser Permanente Northern California

Authors: Friedman GD; Achacoso N; Habel LA

Perm J. 2019;23.

PubMed abstract

Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer

Authors: Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA

J Cancer Surviv. 2018 12;12(6):794-802. Epub 2018-10-18.

PubMed abstract

Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members

Authors: Check DK; Albers KB; Uppal KM; Suga JM; Adams AS; Habel LA; Quesenberry CP; Sakoda LC

Lung Cancer. 2018 Nov;125:51-56. Epub 2018-09-11.

PubMed abstract

Photosensitizing Antihypertensive Drug Use and Risk of Cutaneous Squamous Cell Carcinoma

Authors: Su KA; Habel LA; Achacoso NS; Friedman GD; Asgari MM

Br J Dermatol. 2018 11;179(5):1088-1094. Epub 2018-08-14.

PubMed abstract

A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus

Authors: Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA

Cancer Epidemiol Biomarkers Prev. 2018 05;27(5):525-530.

PubMed abstract

Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?

Authors: Krieger N; Nabavi S; Waterman PD; Achacoso NS; Acton L; Schnitt SJ; Habel LA

Cancer Causes Control. 2018 03;29(3):305-314. Epub 2018-02-09.

PubMed abstract

Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis

Authors: Alford SH; Habel LA; Cancer Research Network Lymphoma Study Group; et al.

Cancer Causes Control. 2018 01;29(1):143-156. Epub 2017-11-30.

PubMed abstract

Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives

Authors: Emerson MA; Banegas MP; Chawla N; Achacoso N; Alexeeff SE; Adams AS; Habel LA

Cancer Res. 2017 12 01;77(23):6770-6776. Epub 2017-11-29.

PubMed abstract

Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery

Authors: Punglia RS; Habel LA; et al.

Breast Cancer Res Treat. 2017 Oct 28.

PubMed abstract

Hydrochlorothiazide use is strongly associated with risk of lip cancer

Authors: Pottegård A; Hallas J; Olesen M; Svendsen MT; Habel LA; Friedman GD; Friis S

J Intern Med. 2017 Oct;282(4):322-331. Epub 2017-06-06.

PubMed abstract

Age at menarche and late adolescent adiposity associated with mammographic density on processed digital mammograms in 24,840 women

Authors: Alexeeff SE; Habel LA; et al.

Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1450-1458. Epub 2017-07-11.

PubMed abstract

Statin use and risk of multiple myeloma: An analysis from the Cancer Research Network

Authors: Epstein MM; Habel LA; Johnson CC; et al.

Int J Cancer. 2017 08 01;141(3):480-487. Epub 2017-05-15.

PubMed abstract

Feasibility of collecting tumor samples of breast cancer patients diagnosed up to 50 years ago in the Child Health and Development Studies

Authors: Krigbaum NY; Rubin RA; Cirillo PM; Terry MB; Habel LA; Morris C; Cohn BA

J Dev Orig Health Dis. 2017 Jun;8(3):331-336. Epub 2017-03-06.

PubMed abstract

Research Letter: Anticholinergic Drugs and the Gallbladder – A Neglected Effect?

Authors: Friedman GD; Achacoso N; Habel LA

Perm J. 2017;21.

PubMed abstract

The Effect of California’s Breast Density Notification Legislation on Breast Cancer Screening

Authors: Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA

J Prim Care Community Health. 2017 Apr;8(2):55-62. Epub 2016-10-31.

PubMed abstract

Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women’s Health Across the Nation (SWAN)

Authors: Jackson EA; Ruppert K; Derby CA; Lian Y; Neal-Perry G; Habel LA; Tepper PG; Harlow SD; Solomon DH

J Am Heart Assoc. 2017 Feb 23;6(3). Epub 2017-02-23.

PubMed abstract

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer

Authors: Hoffmann TJ; Sakoda LC; Habel LA; Quesenberry CP; Schaefer C; Risch N; Van Den Eeden SK; Witte JS; et al.

Nat Commun. 2017 Jan 31;8:14248. Epub 2017-01-31.

PubMed abstract

Circulating sex hormones in relation to anthropometric, sociodemographic and behavioural factors in an international dataset of 12,300 men

Authors: Watts EL; Habel LA; Schaefer CA; Travis RC; et al.

PLoS ONE. 2017;12(12):e0187741. Epub 2017-12-27.

PubMed abstract

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding

Authors: Friedman GD; Achacoso N; Fireman B; Habel LA

J Natl Cancer Inst. 2016 Oct;108(10). Epub 2016-07-05.

PubMed abstract

Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma

Authors: Pottegård A; Schmidt SA; Olesen AB; Achacoso N; Van Den Eeden SK; Hallas J; Sørensen HT; Friis S; Habel LA

Br J Cancer. 2016 Sep 27;115(7):895-900. Epub 2016-08-16.

PubMed abstract

Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early Stage Breast Cancer: The LACE and Pathways Studies

Authors: Jones LW; Kwan ML; Sternfeld B; Habel LA; Kroenke CH; Queensberry CP; Kushi LH; Caan BJ; et al.

Cancer Res. 2016 Sep 15;76(18):5415-22. Epub 2016-08-03.

PubMed abstract

Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer

Authors: Jones LW; Habel LA; Kroenke CH; Kwan ML; Quesenberry CP; Sternfeld B; Kushi LH; Caan BJ; et al.

J Clin Oncol. 2016 Aug 10;34(23):2743-9. Epub 2016-05-23.

PubMed abstract

Case-control study of mammographic density and breast cancer risk using processed digital mammograms

Authors: Habel LA; Lipson JA; Achacoso N; Rothstein JH; Yaffe MJ; Liang RY; Acton L; McGuire V; Whittemore AS; Rubin DL; Sieh W

Breast Cancer Res. 2016 May 21;18(1):53. Epub 2016-05-21.

PubMed abstract

Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study

Authors: Pottegård A; Friis S; Christensen Rd; Habel LA; Gagne JJ; Hallas J

EBioMedicine. 2016 May;7:73-9. Epub 2016-03-14.

PubMed abstract

Time for integrating clinical, lifestyle and molecular data to predict drug responses – Authors’ reply

Authors: Pottegård A; Friis S; Christensen Rd; Habel LA; Gagne JJ; Hallas J

EBioMedicine. 2016 05;7:11. Epub 2016-03-18.

PubMed abstract

Breast cancer multigene testing trends and impact on chemotherapy use

Authors: Ray GT; Mandelblatt J; Habel LA; Ramsey S; Kushi LH; Li Y; Lieu TA

Am J Manag Care. 2016 May 01;22(5):e153-60. Epub 2016-05-01.

PubMed abstract

A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk

Authors: Travis RC; Hamdy FC; Schenk JM; Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group; et al.

Cancer Res. 2016 04 15;76(8):2288-300. Epub 2016-02-26.

PubMed abstract

Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen

Authors: Kwan ML; Shi JM; Habel LA; Song J; Chung JW; Avila CC; Schottinger JE; Cheetham TC; Fletcher SW; Haque R

Breast Cancer Res Treat. 2016 Apr;156(2):379-89. Epub 2016-03-22.

PubMed abstract

Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16 887 Breast Cancer Survivors

Authors: Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML

J Natl Cancer Inst. 2016 Mar;108(3). Epub 2015-12-01.

PubMed abstract

Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community

Authors: Hassett MJ; Jiang W; Habel LA; Nekhlyudov L; Achacoso N; Acton L; Schnitt SJ; Schrag D; Punglia RS

Breast Cancer Res Treat. 2016 Feb;155(3):541-9. Epub 2016-Feb-03.

PubMed abstract

Pioglitazone Use and Risk of Bladder Cancer–Reply

Authors: Ferrara A; Lewis JD; Habel LA

JAMA. 2015 Dec 15;314(23):2568-9.

PubMed abstract

Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study

Authors: Collins LC; Achacoso N; Haque R; Nekhlyudov L; Quesenberry CP; Schnitt SJ; Habel LA; Fletcher SW

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S502-8. Epub 2015-Jun-10.

PubMed abstract

Physical Activity and Risk of Male Breast Cancer

Authors: Arem H; Johnson K; Weiderpass E; Matthews CE; et al.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1898-901. Epub 2015-Sep-24.

PubMed abstract

A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences

Authors: Hoffmann TJ; Van Den Eeden SK; Sakoda LC; Habel LA; Quesenberry CP; Schaefer C; Witte JS; et al.

Cancer Discov. 2015 Aug;5(8):878-91. Epub 2015-06-01.

PubMed abstract

Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes

Authors: Lewis JD; Habel LA; Quesenberry CP; Hedderson MM; Ehrlich SF; Van Den Eeden SK; Ferrara A; et al.

JAMA. 2015 Jul 21;314(3):265-77.

PubMed abstract

Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk

Authors: Brinton LA; Wood SN; Isaacs CJ; Cook MB; et al.

J Clin Oncol. 2015 Jun 20;33(18):2041-50. Epub 2015-05-11.

PubMed abstract

Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System

Authors: Keegan TH; Kurian AW; Gali K; Tao L; Lichtensztajn DY; Hershman DL; Habel LA; Caan BJ; Gomez SL

Am J Public Health. 2015 May;105(5):938-46. Epub 2015-03-19.

PubMed abstract

A hybrid approach to identify subsequent breast cancer using pathology and automated health information data

Authors: Haque R; Shi J; Schottinger JE; Ahmed SA; Chung J; Avila C; Lee VS; Cheetham TC; Habel LA; Fletcher SW; Kwan ML

Med Care. 2015 Apr;53(4):380-5.

PubMed abstract

Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort

Authors: Makboon K; Gold EB; Harvey DJ; Butler LM; Habel LA

Cancer Causes Control. 2015 Mar;26(3):431-42. Epub 2015-01-21.

PubMed abstract

Metformin use and lung cancer risk in patients with diabetes

Authors: Sakoda LC; Ferrara A; Achacoso NS; Peng T; Ehrlich SF; Quesenberry CP; Habel LA

Cancer Prev Res (Phila). 2015 Feb;8(2):174-9.

PubMed abstract

Reply to L. Cabel et al

Authors: Fehrenbacher L; Capra A; Habel L

J Clin Oncol. 2015 Jan 20;33(3):292-3. Epub 2014-12-15.

PubMed abstract

Imputation of the Rare HOXB13 G84E Mutation and Cancer Risk in a Large Population-Based Cohort

Authors: Hoffmann TJ; Sakoda LC; Habel LA; Asgari MM; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS; et al.

PLoS Genet. 2015 Jan;11(1):e1004930. Epub 2015-01-28.

PubMed abstract

Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plans

Authors: Feigelson HS; Carroll NM; Weinmann S; Haque R; Yu CL; Butler MG; Waitzfelder B; Wrenn MG; Capra A; McGlynn EA; Habel LA

Springerplus. 2015;4:24. Epub 2015-01-17.

PubMed abstract

Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009)

Authors: Krieger N; Habel LA; Waterman PD; Shabani M; Ellison-Loschmann L; Achacoso NS; Acton L; Schnitt SJ

NPJ Breast Cancer. 2015;1. Epub 2015-10-07.

PubMed abstract

Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression

Authors: Kwan ML; Kroenke CH; Kushi LH; Quesenberry CP; Habel LA; Caan BJ; et al.

BMC Cancer. 2015;15:278. Epub 2015-04-14.

PubMed abstract

Characterization and Treatment of Local Recurrence Following Breast Conservation for Ductal Carcinoma In Situ

Authors: Greenberg CC; Habel LA; Hughes ME; Nekhlyudov L; Achacoso N; Acton L; Schrag D; Jiang W; Edge S; Weeks JC; Punglia RS

Ann Surg Oncol. 2014 Nov;21(12):3766-73. Epub 2014-05-24.

PubMed abstract

Distant Invasive Breast Cancer Recurrence Risk in Human Epidermal Growth Factor Receptor 2-Positive T1a and T1b Node-Negative Localized Breast Cancer Diagnosed From 2000 to 2006: A Cohort From an Integrated Health Care Delivery System

Authors: Fehrenbacher L; Capra AM; Quesenberry CP; Fulton R; Shiraz P; Habel LA

J Clin Oncol. 2014 Jul 10;32(20):2151-8. Epub 2014-06-02.

PubMed abstract

Complications of herpes zoster in cancer patients

Authors: Tran TN; Ray GT; Horberg MA; Yawn BP; Castillo AL; Saddier P; Habel LA

Scand J Infect Dis. 2014 Jul;46(7):528-32. Epub 2014-05-05.

PubMed abstract

Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer

Authors: Lewis JD; Habel L; Quesenberry C; Mamtani R; Peng T; Bilker WB; Hedderson M; Nessel L; Vaughn DJ; Strom BL; Ferrara A

Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):636-45. Epub 2014-04-25.

PubMed abstract

Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: Differences by age, race, and tumor characteristics

Authors: Sweeney C; Kwan ML; Habel LA; Quesenberry CP; Kushi LH; Caan BJ; et al.

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):714-24. Epub 2014-02-12.

PubMed abstract

Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: Prognostication of short and long term outcomes

Authors: Caan BJ; Sweeney C; Habel LA; Kwan ML; Kroenke CH; Weltzien EK; Quesenberry CP; Castillo A; Factor RE; Kushi LH; Bernard PS

Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):725-34. Epub 2014-02-12.

PubMed abstract

Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer

Authors: Allen LA; Habel L; Pharmacovigilance Research Group; et al.

Med Care. 2014 May;52(5):e30-8.

PubMed abstract

Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression

Authors: Kroenke CH; Sweeney C; Kwan ML; Quesenberry CP; Weltzien EK; Habel LA; Castillo A; Bernard PS; Factor RE; Kushi LH; Caan BJ

Breast Cancer Res Treat. 2014 Apr;144(3):689-99. Epub 2014-03-07.

PubMed abstract

Antidepressants and testicular cancer

Authors: Friedman GD; Schwalbe J; Achacoso N; Meng MV; Kroenke CH; Habel LA

Cancer Causes Control. 2014 Feb;25(2):251-8. Epub 2013-11-26.

PubMed abstract

Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy

Authors: Chan JK; Urban R; Capra AM; Jacoby V; Osann K; Whittemore A; Habel LA

Obstet Gynecol. 2014 Jan;123(1):65-72.

PubMed abstract

Cohort Study of Insulin Glargine and Risk of Breast, Prostate, and Colorectal Cancer Among Patients With Diabetes

Authors: Habel LA; Danforth KN; Quesenberry CP; Capra A; Van Den Eeden SK; Weiss NS; Ferrara A

Diabetes Care. 2013 Dec;36(12):3953-60. Epub 2013-10-29.

PubMed abstract

Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ

Authors: Collins LC; Achacoso N; Haque R; Nekhlyudov L; Fletcher SW; Quesenberry CP; Schnitt SJ; Habel LA

Breast Cancer Res Treat. 2013 Jun;139(2):453-60.

PubMed abstract

Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the Women’s Health Initiative

Authors: Livaudais JC; Lacroix A; Chlebowski RT; Li CI; Habel LA; Simon MS; Thompson B; Erwin DO; Hubbell FA; Coronado GD

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):365-73. Epub 2012 Dec 28.

PubMed abstract

HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease

Authors: Habel LA; Sakoda LC; Achacoso N; Ma XJ; Erlander MG; Sgroi DC; Fehrenbacher L; Greenberg D; Quesenberry CP

Breast Cancer Res. 2013;15(2):R24. Epub 2013-03-14.

PubMed abstract

The Epidemiology of Herpes Zoster in Patients with Newly Diagnosed Cancer

Authors: Habel LA; Ray GT; Silverberg MJ; Horberg MA; Yawn BP; Castillo AL; Quesenberry CP Jr; Li Y; Sadier P; Tran TN

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):82-90. Epub 2012 Nov 1.

PubMed abstract

Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007

Authors: Kurian AW; Lichtensztajn DY; Keegan TH; Leung RW; Shema SJ; Hershman DL; Kushi LH; Habel LA; Kolevska T; Caan BJ; Gomez SL

Breast Cancer Res Treat. 2013 Jan;137(1):247-60. Epub 2012 Nov 9.

PubMed abstract

Utilization of HER2 genetic testing in a multi-institutional observational study

Authors: Goddard KA; Bowles EJ; Feigelson HS; Habel LA; Alford SH; McCarty CA; Nekhlyudov L; Onitilo AA; Rahm AK; Webster JA

Am J Manag Care. 2012 Nov;18(11):704-12.

PubMed abstract

Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review

Authors: Braithwaite D; Kwan ML; Kroenke CH; Habel L; Caan B; et al.

Breast Cancer Res Treat. 2012 Nov;136(2):521-33. Epub 2012 Sep 29.

PubMed abstract

Antihypertensive Drugs and Lip Cancer in Non-Hispanic Whites

Authors: Friedman GD; Asgari MM; Warton EM; Chan J; Habel LA

Arch Intern Med. 2012 Sep 10;172(16):1246-51.

PubMed abstract

Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study

Authors: Bowles EJ; Habel LA; Pharmacovigilance Study Team; et al.

J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305.

PubMed abstract

Patterns of Adjuvant Hormonal Therapy Use in the Northern California Breast Cancer Family Registry

Authors: Livaudais JC; Li C; John EM; Terry MB; Daly M; Buys SS; Habel L; Thompson B; Yanez ND; Coronado GD

J Womens Health (Larchmt). 2012 Sep;21(9):950-8. Epub 2012 Jun 25.

PubMed abstract

Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCIS

Authors: Nekhlyudov L; Habel LA; Achacoso N; Jung I; Haque R; Collins LC; Schnitt SJ; Quesenberry CP Jr; Fletcher SW

J Natl Cancer Inst. 2012 Apr 18;104(8):614-21. Epub 2012 Apr 5.

PubMed abstract

Validity of Eight Integrated Healthcare Delivery Organizations’ Administrative Clinical Data to Capture Breast Cancer Chemotherapy Exposure

Authors: Delate T; Habel LA; Wagner E; et al.

Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):673-80. Epub 2012 Feb 15.

PubMed abstract

A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

Authors: Kratz JR; Van Den Eeden SK; Quesenberry CP; Habel LA; Jablons DM; et al.

Lancet. 2012 Mar 3;379(9818):823-32. Epub 2012 Jan 27.

PubMed abstract

Risk of cancer in patients exposed to gabapentin in two electronic medical record systems

Authors: Irizarry MC; Webb DJ; Boudiaf N; Logie J; Habel LA; Udaltsova N; Friedman GD

Pharmacoepidemiol Drug Saf. 2012 Feb;21(2):214-25. Epub 2011 Dec 6.

PubMed abstract

Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer

Authors: Livaudais JC; Hershman DL; Habel L; Kushi L; Gomez SL; Li CI; Neugut AI; Fehrenbacher L; Thompson B; Coronado GD

Breast Cancer Res Treat. 2012 Jan;131(2):607-17. Epub 2011 Sep 16.

PubMed abstract

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults

Authors: Habel LA; Fireman BH; Go AS; Nguyen-Huynh MN; Selby JV; et al.

JAMA. 2011 Dec 28;306(24):2673-83. Epub 2011 Dec 12.

PubMed abstract

ADHD drugs and serious cardiovascular events in children and young adults

Authors: Cooper WO; Habel LA; Fireman BH; Ray WA; et al.

N Engl J Med. 2011 Nov 17;365(20):1896-904. Epub 2011 Nov 1.

PubMed abstract

Re: a case-control study of levothyroxine and the risk of colorectal cancer

Authors: Friedman GD; Schwalbe JS; Habel LA

J Natl Cancer Inst. 2011 Nov 2;103(21):1637-9. Epub 2011 Oct 18.

PubMed abstract

Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study

Authors: Kwan ML; Greenlee H; Lee VS; Castillo A; Gunderson EP; Habel LA; Kushi LH; Sweeney C; Tam EK; Caan BJ

Breast Cancer Res Treat. 2011 Nov;130(1):195-205. Epub 2011 May 11.

PubMed abstract

Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women

Authors: Kabat GC; Kim MY; Woods NF; Habel LA; Messina CR; Wactawski-Wende J; Stefanick ML; Chlebowski RT; Wassertheil-Smoller S; Rohan TE

Cancer Causes Control. 2011 Oct;22(10):1415-24. Epub 2011 Jul 13.

PubMed abstract

Metabolic syndrome and mammographic density: The study of women’s health across the nation (SWAN)

Authors: Conroy SM; Butler LM; Harvey D; Gold EB; Sternfeld B; Greendale GA; Habel LA

Int J Cancer. 2010 Nov 23.

PubMed abstract

Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

Authors: Ganz PA; Habel LA; Weltzien EK; Caan BJ; Cole SW

Breast Cancer Res Treat. 2011 Sep;129(2):549-56. Epub 2011 Apr 11.

PubMed abstract

A method to estimate off-schedule observations in a longitudinal study

Authors: Reeves KW; Stone RA; Modugno F; Ness RB; Vogel VG; Weissfeld JL; Habel LA; Vuga M; Cauley JA

Ann Epidemiol. 2011 Apr;21(4):297-303.

PubMed abstract

Cohort study of pioglitazone and cancer incidence in patients with diabetes

Authors: Ferrara A; Lewis JD; Quesenberry CP Jr; Peng T; Strom BL; Van den Eeden SK; Ehrlich SF; Habel LA

Diabetes Care. 2011 Apr;34(4):923-9.

PubMed abstract

Norepinephrine antagonists and cancer risk

Authors: Friedman GD; Udaltsova N; Habel LA

Int J Cancer. 2011 Feb 1;128(3):737-8; author reply 739.

PubMed abstract

Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus

Authors: Yang YX; Habel LA; Capra AM; Achacoso NS; Ferrara A; Levin TR; Lewis JD; Quesenberry CP Jr

Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3027-36. Epub 2010 Oct 11.

PubMed abstract

Lipophilic statin use and risk of breast cancer subtypes

Authors: Woditschka S; Habel LA; Udaltsova N; Friedman GD; Sieh W

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2479-87. Epub 2010 Aug 20.

PubMed abstract

Mammographic density and risk of second breast cancer after ductal carcinoma in situ

Authors: Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP Jr

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2488-95.

PubMed abstract

Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories

Authors: Baehner FL; Achacoso N; Maddala T; Shak S; Quesenberry CP Jr; Goldstein LC; Gown AM; Habel LA

J Clin Oncol. 2010 Oct 1;28(28):4300-6. Epub 2010 Aug 9.

PubMed abstract

Diabetes and cancer: a consensus report

Authors: Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D

CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21. Epub 2010 Jun 16.

PubMed abstract

Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans

Authors: Haque R; Achacoso NS; Fletcher SW; Nekhlyudov L; Collins LC; Schnitt SJ; Quesenberry CP Jr; Habel LA

Am J Manag Care. 2010 May;16(5):351-60.

PubMed abstract

Physical activity and change in mammographic density: the Study of Women’s Health Across the Nation

Authors: Conroy SM; Butler LM; Harvey D; Gold EB; Sternfeld B; Oestreicher N; Greendale GA; Habel LA

Am J Epidemiol. 2010 May 1;171(9):960-8. Epub 2010 Mar 30.

PubMed abstract

Active, but not passive cigarette smoking was inversely associated with mammographic density

Authors: Butler LM; Gold EB; Conroy SM; Crandall CJ; Greendale GA; Oestreicher N; Quesenberry CP Jr; Habel LA

Cancer Causes Control. 2010 Feb;21(2):301-11.

PubMed abstract

Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients

Authors: Collins LC; Quesenberry CP Jr; Habel LA; et al.

Am J Surg Pathol. 2009 Dec;33(12):1802-8.

PubMed abstract

Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened

Authors: Friedman GD; Udaltsova N; Chan J; Quesenberry CP Jr; Habel LA

Cancer Causes Control. 2009 Dec;20(10):1821-35.

PubMed abstract

Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity

Authors: Friedman GD; Jiang SF; Udaltsova N; Quesenberry CP Jr; Chan J; Habel LA

Int J Cancer. 2009 Nov 1;125(9):2173-8.

PubMed abstract

Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study

Authors: Flick ED; Habel LA; Chan KA; Haque R; Quinn VP; Van Den Eeden SK; Sternfeld B; Orav EJ; Seeger JD; Quesenberry CP Jr; Caan BJ

Drugs. 2009 Jul 30;69(11):1445-57.

PubMed abstract

Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery

Authors: Nekhlyudov L; Habel LA; Achacoso NS; Jung I; Haque R; Collins LC; Schnitt SJ; Quesenberry CP Jr; Fletcher SW

J Clin Oncol. 2009 Jul 1;27(19):3211-6. Epub 2009 May 11.

PubMed abstract

Pharmaceuticals that cause mammary gland tumors in animals: findings in women

Authors: Friedman GD; Jiang SF; Udaltsova N; Chan J; Quesenberry CP Jr; Habel LA

Breast Cancer Res Treat. 2009 Jul;116(1):187-94. Epub 2008 Jul 16.

PubMed abstract

Longitudinal association of anthropometry with mammographic breast density in the Study of Women’s Health Across the Nation

Authors: Reeves KW; Stone RA; Modugno F; Ness RB; Vogel VG; Weissfeld JL; Habel LA; Sternfeld B; Cauley JA

Int J Cancer. 2009 Mar 1;124(5):1169-77.

PubMed abstract

Race, ethnicity, sex and temporal differences in Barrett’s oesophagus diagnosis: a large community-based study, 1994-2006

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P

Gut. 2009 Feb;58(2):182-8. Epub 2008 Oct 31.

PubMed abstract

Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting

Authors: Habel LA; Achacoso NS; Haque R; Nekhlyudov L; Fletcher SW; Schnitt SJ; Collins LC; Geiger AM; Puligandla B; Acton L; Quesenberry CP Jr

Breast Cancer Res. 2009;11(6):R85. Epub 2009 Nov 18.

PubMed abstract

Mothers of children diagnosed with attention-deficit/hyperactivity disorder: health conditions and medical care utilization in periods before and after birth of the child

Authors: Ray GT; Croen LA; Habel LA

Med Care. 2009 Jan;47(1):105-14.

PubMed abstract

Hemochromatosis gene status as a risk factor for Barrett’s esophagus

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore GJ; Quesenberry C; Buffler P

Dig Dis Sci. 2008 Dec;53(12):3095-102. Epub 2008 May 10.

PubMed abstract

Iron intake and body iron stores as risk factors for Barrett’s esophagus: a community-based study

Authors: Corley DA; Kubo A; Levin TR; Habel L; Zhao W; Leighton P; Rumore G; Quesenberry C; Buffler P; Block G

Am J Gastroenterol. 2008 Dec;103(12):2997-3004. Epub 2008 Oct 1.

PubMed abstract

Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus

Authors: Lewis JD; Capra AM; Achacoso NS; Ferrara A; Levin TR; Quesenberry CP Jr; Habel LA

Gastroenterology. 2008 Dec;135(6):1914-23, 1923.e1. Epub 2008 Sep 13.

PubMed abstract

Menstrual and reproductive factors in relation to mammographic density: the Study of Women’s Health Across the Nation (SWAN)

Authors: Butler LM; Gold EB; Greendale GA; Crandall CJ; Modugno F; Oestreicher N; Quesenberry CP Jr; Habel LA

Breast Cancer Res Treat. 2008 Nov;112(1):165-74. Epub 2007 Dec 9.

PubMed abstract

Helicobacter pylori and gastroesophageal reflux disease: a case-control study

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P; Parsonnet J

Helicobacter. 2008 Oct;13(5):352-60.

PubMed abstract

Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors

Authors: Kwan ML; Habel LA; Flick ED; Quesenberry CP; Caan B

Breast Cancer Res Treat. 2008 Jun;109(3):573-9. Epub 2007 Aug 3.

PubMed abstract

Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Rumore G; Quesenberry C; Buffler P; Parsonnet J

Gut. 2008 Jun;57(6):727-33. Epub 2007 Sep 25.

PubMed abstract

Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

Authors: Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L

J Natl Cancer Inst. 2008 Apr 16;100(8):597-8; author reply 599. Epub 2008 Apr 8.

PubMed abstract

Physical activity and mammographic density in a cohort of midlife women

Authors: Oestreicher N; Capra A; Bromberger J; Butler LM; Crandall CJ; Gold EB; Greendale GA; Modugno F; Sternfeld B; Habel LA

Med Sci Sports Exerc. 2008 Mar;40(3):451-6.

PubMed abstract

Glycemic status and risk of prostate cancer

Authors: Darbinian JA; Ferrara AM; Van Den Eeden SK; Quesenberry CP Jr; Fireman B; Habel LA

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):628-35.

PubMed abstract

Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

Authors: Friedman GD; Flick ED; Udaltsova N; Chan J; Quesenberry CP Jr; Habel LA

Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):27-36.

PubMed abstract

Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses

Authors: Oestreicher N; Friedman GD; Jiang SF; Chan J; Quesenberry C Jr; Habel LA

Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1268-72.

PubMed abstract

Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients

Authors: Collins LC; Achacoso NA; Nekhlyudov L; Fletcher SW; Haque R; Quesenberry CP Jr; Alshak NS; Puligandla B; Brodsky GL; Schnitt SJ; Habel LA

Mod Pathol. 2007 Nov;20(11):1149-55. Epub 2007 Aug 31.

PubMed abstract

Statin use and risk of prostate cancer in the California Men’s Health Study cohort

Authors: Flick ED; Habel LA; Van Den Eeden SK; Quesenberry CP Jr; Sternfeld B; Whitmer RA; Caan BJ; et al.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2218-25. Epub 2007 Oct 30.

PubMed abstract

Medical therapy for diabetes is associated with increased use of lower endoscopy

Authors: Lewis JD; Capra AM; Achacoso NS; Ferrara A; Levin TR; Quesenberry CP Jr; Habel LA

Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1195-202.

PubMed abstract

Mammographic density in a multiethnic cohort

Authors: Habel LA; Quesenberry C; Sternfeld B; et al.

Menopause. 2007 Sep-Oct;14(5):891-9.

PubMed abstract

The association between mammographic breast density and bone mineral density in the study of women’s health across the nation

Authors: Crandall CJ; Zheng Y; Karlamangla A; Sternfeld B; Habel LA; Oestreicher N; Johnston J; Cauley JA; Greendale GA

Ann Epidemiol. 2007 Aug;17(8):575-83. Epub 2007 May 29.

PubMed abstract

NSAIDs and breast cancer recurrence in a prospective cohort study

Authors: Kwan ML; Habel LA; Slattery ML; Caan B

Cancer Causes Control. 2007 Aug;18(6):613-20. Epub 2007 Apr 3.

PubMed abstract

Correlates of screening sigmoidoscopy use among men in a large nonprofit health plan

Authors: Haque R; Quinn VP; Habel LA; Enger SM; Sternfeld B; Van Den Eeden SK; Sadler M; Chiu V; Caan B

Cancer. 2007 Jul 15;110(2):275-81.

PubMed abstract

Abdominal obesity and body mass index as risk factors for Barrett’s esophagus

Authors: Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA

Gastroenterology. 2007 Jul;133(1):34-41; quiz 311. Epub 2007 Apr 25.

PubMed abstract

Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women

Authors: Friedman GD; Oestreicher N; Chan J; Quesenberry CP Jr; Udaltsova N; Habel LA

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2102-6.

PubMed abstract

Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity

Authors: Ray GT; Levine P; Croen LA; Bokhari FA; Hu TW; Habel LA

Arch Pediatr Adolesc Med. 2006 Oct;160(10):1063-9.

PubMed abstract

Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer

Authors: Caan BJ; Gunderson EP; Habel L; Sternfeld B; Pierce JP; et al.

Breast Cancer Res Treat. 2006 Sep;99(1):47-57. Epub 2006 Mar 16.

PubMed abstract

Barrett’s esophagus and medications that relax the lower esophageal sphincter

Authors: Corley DA; Levin TR; Habel LA; Buffler PA

Am J Gastroenterol. 2006 May;101(5):937-44.

PubMed abstract

Use of raloxifene among women with a history of breast cancer

Authors: Habel LA; Pressman A; Ettinger B; Sidney S; Suh-Burgmann B; Fehrenbacher L; Quesenberry CP

Breast Cancer Res Treat. 2006 Mar;96(2):123-9.

PubMed abstract

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

Authors: Habel LA; Quesenberry CP; et al.

Breast Cancer Res. 2006;8(3):R25. Epub 2006 May 31.

PubMed abstract

California Men’s Health Study (CMHS): a multiethnic cohort in a managed care setting

Authors: Enger SM; Van Den Eeden SK; Sternfeld B; Loo RK; Quesenberry CP Jr; Rowell S; Sadler MC; Schaffer DM; Habel LA; Caan BJ

BMC Public Health. 2006 Jun 30;6:172.

PubMed abstract

Treatment with stimulants among youths in a large California health plan

Authors: Habel LA; Schaefer CA; Levine P; Bhat AK; Elliott G

J Child Adolesc Psychopharmacol. 2005 Feb;15(1):62-7.

PubMed abstract

Mammographic density and breast cancer after ductal carcinoma in situ

Authors: Habel LA; Dignam JJ; Land SR; Salane M; Capra AM; Julian TB

J Natl Cancer Inst. 2004 Oct 6;96(19):1467-72.

PubMed abstract

The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors

Authors: Efird JT; Friedman GD; Sidney S; Klatsky A; Habel LA; Udaltsova NV; Van den Eeden S; Nelson LM

J Neurooncol. 2004 May;68(1):57-69.

PubMed abstract

Risk of subsequent cancer following invasive or in situ squamous cell skin cancer

Authors: Efird JT; Friedman GD; Habel L; Tekawa IS; Nelson LM

Ann Epidemiol. 2002 Oct;12(7):469-75.

PubMed abstract

Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US

Authors: Habel LA; Zhao W; Stanford JL

Cancer Causes Control. 2002 Jun;13(5):427-34.

PubMed abstract

Surveillance and survival in Barrett’s adenocarcinomas: a population-based study

Authors: Corley DA; Levin TR; Habel LA; Weiss NS; Buffler PA

Gastroenterology. 2002 Mar;122(3):633-40.

PubMed abstract

CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma

Authors: Shibata A; Parsonnet J; Longacre TA; Garcia MI; Puligandla B; Davis RE; Vogelman JH; Orentreich N; Habel LA

Carcinogenesis. 2002 Mar;23(3):419-24.

PubMed abstract

Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists

Authors: Shibata A; Longacre TA; Puligandla B; Parsonnet J; Habel LA

Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):75-8.

PubMed abstract

Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort

Authors: Habel LA; Van Den Eeden SK; Friedman GD

Prostate. 2000 May 1;43(2):136-43.

PubMed abstract

Cimetidine use and risk of breast, prostate, and other cancers

Authors: Habel LA; Levin TR; Friedman GD

Pharmacoepidemiol Drug Saf. 2000 Mar;9(2):149-55.

PubMed abstract

Epidemiology of ductal carcinoma in situ

Authors: Habel LA

Semin Breast Dis. 2000;3:187-99.

Barbiturates and lung cancer: a re-evaluation

Authors: Friedman GD; Habel LA

Int J Epidemiol. 1999 Jun;28(3):375-9.

PubMed abstract

Barbiturates, smoking, and bladder cancer risk

Authors: Habel LA; Bull SA; Friedman GD

Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1049-50.

PubMed abstract

Back To Top